Latest DKA guidelines
Reading File
Finding Sources
Searching PubMed
"diabetic ketoacidosis" AND management
Searching the Web
DKA guidelines 2024 2025 ADA management diabetic ketoacidosis
Reading File
Reading File
Reading Article
Reading Article
Reading File
Reading File
Reading Web Page
DKA diagnostic criteria management guidelines 2024 fluid insulin potassium
Reading File
I have sufficient data from the textbooks and the 2024 ADA consensus. Let me now compile the comprehensive response.
DKA: Current Guidelines (Updated 2024)
The 2024 ADA Consensus Report on Hyperglycemic Crises (June 2024) is the most current authoritative guideline - it replaced the 2009 version and introduced revised diagnostic and resolution criteria. Here is a structured summary.
Diagnostic Criteria (2024 ADA)
DKA is defined by all three of the following ("DKA triad"):
| Feature | Value |
|---|---|
| Hyperglycemia | Blood glucose > 11 mmol/L (200 mg/dL), OR known diabetes |
| Ketonemia/ketonuria | Serum ketones ≥ 3.0 mmol/L, OR urine ketones 2+ or more |
| Acidosis | Venous/arterial pH < 7.3, AND/OR serum bicarbonate < 18 mmol/L |
Severity Classification:
| Severity | pH | HCO₃ | Mental Status |
|---|---|---|---|
| Mild | 7.25 - 7.30 | 15-18 | Alert |
| Moderate | 7.00 - 7.24 | 10-14 | Alert/drowsy |
| Severe | < 7.00 | < 10 | Stupor/coma |
Note: Glucose may be normal in euglycemic DKA (especially with SGLT2 inhibitors, pregnancy, or recent insulin use).
Common Precipitants
- Most common: Infection, insulin omission/non-adherence, new-onset T1DM, ACS
- Drugs to remember: SGLT2 inhibitors (euglycemic DKA), corticosteroids, clozapine, olanzapine, cocaine
- Other: Pancreatitis, stroke, PE, thyrotoxicosis, Cushing syndrome
Management: The Four Pillars
1. IV Fluids
- Fluid deficit in severe DKA is typically 3-5 L in adults (70-90 mL/kg in children).
- Shock/severe hypovolemia: Isotonic crystalloid (0.9% NaCl or balanced solution) as rapidly as possible in adults; 20 mL/kg boluses in children until systolic BP > 80 mmHg.
- No shock: 1 L over the first hour in adults, then 2 L over 1-3 hours, followed by 0.45% NaCl at a slower rate.
- Balanced crystalloids (e.g., Plasmalyte, Hartmann's) are increasingly favored over normal saline to avoid hyperchloremic acidosis, though evidence is still accumulating.
- Add 5% dextrose to the infusion when glucose drops to 14-17 mmol/L (250-300 mg/dL) to allow continued insulin infusion while preventing hypoglycemia.
2. Insulin
- Do not start insulin until K⁺ ≥ 3.5 mmol/L - replace potassium first, then start insulin.
- Standard dose: IV regular insulin infusion at 0.1 units/kg/hour (or 0.05 units/kg/hour for mild DKA in children).
- IV bolus: An initial IV bolus of 0.1 units/kg is optional in adults; not recommended in children (risk of cerebral edema).
- Target glucose fall: 2.8-4.2 mmol/L/hour (50-75 mg/dL/hour). If not falling in first hour, double the insulin rate.
- Subcutaneous insulin (rapid-acting analogues, e.g., aspart or lispro every 1-2 hrs) is a safe, effective alternative in mild-to-moderate DKA in selected patients - a 2024 systematic review (PMID 39090718) found no difference in time to DKA resolution, mortality, or hypoglycemia vs. IV insulin, with a trend toward shorter hospital stay.
- Transition to SC insulin: When glucose < 14 mmol/L, acidosis resolved, and patient tolerating oral intake. Overlap SC insulin with IV infusion for 30-60 min before stopping IV.
3. Potassium Replacement
This is the most time-critical electrolyte.
| Serum K⁺ | Action |
|---|---|
| < 3.5 mmol/L | Give K⁺ 20-40 mEq/hr, hold insulin until K⁺ ≥ 3.5 |
| 3.5 - 5.0 mmol/L | Add 20-40 mEq/L to IV fluids |
| > 5.0 mmol/L | Hold potassium, recheck every 2 hours |
- Use a mix of KCl and KPO₄ to simultaneously correct phosphate depletion. Sole KCl risks hyperchloremic acidosis.
- Monitor K⁺ hourly during early treatment (every 2 hours once stable).
4. Identify and Treat the Precipitant
- Blood cultures, CXR, urinalysis, ECG
- Troponin in adults (ACS as precipitant)
- Amylase/lipase if pancreatitis suspected
Other Electrolytes
- Bicarbonate: NOT routinely recommended. Consider only if pH < 6.9 (severe life-threatening acidosis) with careful titration - risk of paradoxical CNS acidosis, hypokalemia, and delayed ketone clearance.
- Phosphate: Not routinely replaced unless < 0.32 mmol/L or respiratory/cardiac compromise; use KPO₄ as part of K⁺ replacement.
- Magnesium: Replace if hypomagnesemia documented.
Resolution Criteria (2024 ADA - Updated)
DKA is considered resolved when ALL of:
- Blood glucose < 11 mmol/L (200 mg/dL)
- Serum bicarbonate ≥ 15 mmol/L
- Anion gap ≤ 12 mEq/L (new in 2024 - this replaced the old pH > 7.3 criterion)
- Patient tolerating oral intake
The 2024 update specifically added normalization of the anion gap as a resolution criterion, as pH and bicarbonate can normalize before ketoacidosis fully resolves.
Special Situations
| Condition | Key Modifications |
|---|---|
| SGLT2-inhibitor euDKA | Glucose may be normal/near-normal; stop SGLT2i; standard DKA protocol applies |
| Pregnancy | Lower threshold for diagnosis (glucose may be normal); fetal monitoring essential; aggressive management |
| DKA + CKD/ESRD | No routine fluid bolus if euvolemic; small aliquots (250 mL) if hypovolemic; lower insulin dose (0.05 units/kg/hr); no routine K⁺ supplementation; hemodialysis if severe hyperkalemia |
| DKA + Heart failure | Strict hemodynamic monitoring; restrict fluids; avoid aggressive volume replacement |
| DKA + HHS overlap | Aggressive hydration over first 12 hours; higher insulin dose (0.1 units/kg/hr); frequent K⁺ monitoring |
| Pediatric DKA | No IV insulin bolus; 0.05-0.1 units/kg/hr; watch for cerebral edema (most feared complication); 2-3% risk, treat with mannitol 0.5-1 g/kg IV |
| Intubation | Avoid if possible (hard to match Kussmaul ventilation); if intubated, maintain hyperventilation to prevent worsening acidosis |
Monitoring
- Glucose: hourly
- Electrolytes, BUN, creatinine, anion gap: every 2-4 hours
- Venous pH/bicarbonate: every 2-4 hours (venous pH is adequate; arterial line only if clinical need)
- Urine output: > 0.5 mL/kg/hr in adults; 1-2 mL/kg/hr in children
Key 2024 ADA Updates vs. Prior Guidelines
- Revised resolution criteria - anion gap normalization now required (≤ 12 mEq/L), not just pH/HCO₃
- Euglycemic DKA formally recognized and explicitly addressed
- Subcutaneous insulin protocols endorsed as an alternative to IV infusion in mild-moderate DKA
- Balanced crystalloids acknowledged as reasonable alternatives to normal saline
- Updated HHS overlap criteria and management guidance
Key Sources:
- ROSEN's Emergency Medicine, 9th ed., Ch. 115 (Rosen's Emergency Medicine, p. 2542-2545)
- Goldman-Cecil Medicine, International Ed., Ch. 210 (Goldman-Cecil Medicine, p. 2484-2486)
- 2024 ADA Consensus Report review - Rodriguez Alvarez et al., Cleveland Clinic J Med 2025 [PMID: 40032308]
- SC vs. IV insulin meta-analysis - Alnuaimi et al., BMC Endocr Disord 2024 [PMID: 39090718]
This is a shared conversation. Sign in to Orris to start your own chat.